Genomics of varicose veins and chronic venous insufficiency

Seminars in Vascular Surgery

Volumn 26, Issue 1, 2013, Pages 2-13

  Markovic, Jovan N ^a   Shortell, Cynthia K ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DNA;

ADULT; AGED; CHRONIC VEIN INSUFFICIENCY; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC DISORDER; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOMICS; HUMAN; HUMAN GENOME; HUMAN TISSUE; INFLAMMATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; UPREGULATION; VARICOSIS;

AGED; CASE-CONTROL STUDIES; CHRONIC DISEASE; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; RISK FACTORS; VARICOSE VEINS; VENOUS INSUFFICIENCY;

EID: 84881527943     PISSN: 08957967     EISSN: 15584518     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2013.04.003     Document Type: Review

References (42)

1. Criqui M.H., Jamosmos M., Fronek A., et al. Chronic venous disease in an ethnically diverse population: the San Diego Population Study. Am J Epidemiol 2003, 58:448-456.
2. Eklof B., Perrin M., Delis K.T., et al. Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document. J Vasc Surg 2009, 49:498-501.
3. Lawrence P.F., Gazak G.C. Epidemiology of chronic venous insufficiency. Chronic Venous Insufficiency 2000, 3-9. Springer, London, UK. J. Ballard, J.J. Bergan (Eds.).
4. Nelzen O., Berqvist D., Lindhagen A. The prevalence of chronic lower-limb ulceration has been underestimated: results of a validated population questionnaire. Br J Surg 1996, 83:255-258.
5. Gloviczki P., Comerota A.J., Dalsing M.C., et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011, 53(Suppl):2S-48.
6. Gloviczki P., Gloviczki M.L. Guidelines for the management of varicose veins. Phlebology 2012, 27(Suppl 1):2-9.
7. Markovic J.N., Shortell C.K. Endovenous laser ablation: strategies for treating multilevel disease. Perspect Vasc Surg Endovasc Ther 2009, 21:73-81.
8. Valencia I.C., Falabella A., Krisner R.S., et al. Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol 2001, 44:401-421.
9. Coleridge Smith P.D., Bergan J.J. Inflammation in venous disease. Molecular Basis for Microcirculatory Disorders 2003, 489. Springer-Verlag, Paris. G.W. Schmid-Schönbein, N. Granger (Eds.).
10. Meissner M.H., Moneta G., Burnand K., et al. The hemodynamics and diagnosis of venous disease. J Vasc Surg 2007, 46(Suppl S):4S-24S. Review.
11. Takase S., Schmid-Schönbein G., Bergan J.J. Leukocyte activation in patients with venous insufficiency. J Vasc Surg 1999, 30:148-156.
12. Ono T., Bergan J.J., Schmid-Schönbein G.W., et al. Monocyte infiltration into venous valves. J Vasc Surg 1998, 27:158-166.
13. Takase S., Bergan J.J., Schmid-Schönbein G.W. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg 2000, 14:427-435.
14. Sansilvestri-Morel P., Rupin A., Badier-Commander C., et al. Imbalance in the synthesis of collagen type I and collagen type III in smooth muscle cells derived from human varicose veins. J Vasc Res 2001, 38:560.
15. Wolanska M., Sobolewski K., Glowinski S., et al. Glycosaminoglycans of normal veins and their alterations in varicose veins and varicose veins complicated by thrombophlebitis. Eur Surg Res 2001, 33:28.
16. Shoab S.S., Scurr J.J., Coleridge-Smith P.D. Increased plasma vascular endothelial growth factor among patients with chronic venous disease. J Vasc Surg 1998, 28:535.
17. Kowalewski R., Malkowski A., Sobolewski K., et al. Evaluation of aFGF/bFGF and FGF signaling pathway in the wall of varicose veins. J Surg Res 2009, 155:165-172.
18. Jacob T., Hingorani A., Ascher E. Overexpression of transforming growth factor 1 correlates with increased synthesis of nitric oxide synthase in varicose veins. J Vasc Surg 2005, 41:523-530.
19. Markovic JN, Shortell CK. Gene expression profiles in patients with chronic venous insufficiency and varicose veins. Presented at the 25th Annual ACP Congress, Los Angeles CA, November 2011.
20. Markovic JN, Shortell CK. New frontiers: genomics of chronic venous insufficiency and varicose veins. Presented at the 5th Annual Meeting: What's New in Venous Disease 2013, Durham, NC, February 2013.
21. Lowell R.C., Gloviczki P., Miller V.M. In vitro evaluation of endothelial and smooth muscle function of primary varicose veins. J Vasc Surg 1992, 16:679-686.
22. Sansilvestri-Morel P., Rupin A., Jaisson S., et al. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation 2002, 106:479-483.
23. Norgauer J., Hildenbrand T., Idzko M., et al. Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metalloproteinases in venous leg ulcers. Br J Dermatol 2002, 147:1180-1186.
24. Bergan J.J., Schmid-Schönbein G.W., Smith P.D. Chronic venous disease. N Engl J Med 2006, 355:488-498.
25. Coggins K.G., Latour A., Nguyen M.S., et al. Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus. Nat Med 2002, 8:91-92.
26. Nandy A., Jenatschke S., Hartung B. Genomic structure and transcriptional regulation of the human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene. J Mol Endocrinol 2003, 31:105-121.
27. Pichaud F., Delage-Mourroux R., Pidoux E., et al. Chromosomal localization of the type-I 15-PGDH gene to 4q34-q35. Hum Genet 1997, 99:279-281.
28. Xu W., Ahmad A., Dagenais S., et al. Chromosome 4q deletion syndrome: narrowing the cardiovascular critical region to 4q32.2-q34.3. Am J Med Genet 2011, 158A:635-640.
29. Bunting S., Moncada S., Vane J.R. The prostacyclin-thromboxane A2 balance: pathophysiological and therapeutic implications. Br Med Bull 1983, 39:271-276.
30. Gemmati D., Federici F., Catozzi L. DNA-array of gene variants in venous leg ulcers: detection of prognostic indicators. J Vasc Surg 2009, 50:1444-1451.
31. Badier-Commander C., Couvelard A., Henin D., et al. Smooth muscle cell modulation and cytokine overproduction in varicose veins: an in situ study. J Pathol 2001, 193:398-407.
32. Jacob M.P., Badier-Commander C., Fontaine V., et al. Extracellular matrix remodeling in the vascular wall. Pathol Biol (Paris) 2001, 49:326-332.
33. Dennis J., Meehan D.T., Delimont D. Collagen XIII induced in vascular endothelium mediates alpha1beta1 integrin-dependent transmigration of monocytes in renal fibrosis. Am J Pathol 2010, 177:2527-2540.
34. Boot-Handford R.P., Tuckwell D.S., Plumb D.A., et al. A novel and highly conserved collagen (pro(alpha)1(XXVII)) with a unique expression pattern and unusual molecular characteristics establishes a new clade within the vertebrate fibrillar collagen family. J Biol Chem 2003, 278:31067-31077.
35. Sabatie R., Finett P., Adelaid J., et al. Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer. PLoS One 2011, 6:e27656.
36. Yoshizumi M., Abe J., Tsuchiya K., et al. Stress and vascular responses: atheroprotective effect of laminar fluid shear stress in endothelial cells: possible role of mitogen-activated protein kinases. J Pharmacol Sci 2003, 91:172-176.
37. Traub O., Berk B.C. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 1998, 18:677-685.
38. Fukuda S., Schmid-Schonbein G.W. Regulation of CD18 expression on neutrophils in response to fluid shear stress. Proc Natl Acad Sci U S A 2003, 100:13152-13157.
39. Ohura N., Yamamoto K., Ichioka S., et al. Global analysis of shear stress-responsive genes in vascular endothelial cells. J Atheroscler Thromb 2003, 10:304-313.
40. Passerini A.G., Milsted A., Rittgers S.E. Shear stress magnitude and directionality modulate growth factor gene expression in preconditioned vascular endothelial cells. J Vasc Surg 2003, 37:182-190.
41. Topper J., Cai J., Falb D. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A 1996, 93:10417-10422.
42. Francesco L., Totani L., Dovizio M. Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-a biosynthesis via heme oxygenase-1 in human endothelial cells. Circ Res 2009, 104:506-513.